Reciprocal regulation of GAS5 lncRNA levels and mTOR inhibitor action in prostate cancer cells

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0045|75|7|693-705

ISSN： 0270-4137

Source： THE PROSTATE, Vol.75, Iss.7, 2015-05, pp. : 693-705

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synergistic effects of histone deacetylase inhibitor in combination with mTOR inhibitor in the treatment of prostate carcinoma

By            

International Journal of Molecular Medicine, Vol. 31, Iss. 2, 2013-01 ,pp. : 339-346

Spandidos Publications

Access to resources Recommend Favorite

The mTOR Pathway in Breast Cancer

By Hynes Nancy   Boulay Anne  

Journal of Mammary Gland Biology and Neoplasia, Vol. 11, Iss. 1, 2006-01 ,pp. : 53-61

Springer Publishing Company

Access to resources Recommend Favorite

Vardenafil, an inhibitor of phosphodiesterase-5, blocks advanced glycation end product (AGE)-induced up-regulation of monocyte chemoattractant protein-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression via elevation of cGMP

By Ishibashi Yuji  

Clinical and Experimental Medicine, Vol. 11, Iss. 2, 2011-06 ,pp. : 131-135

Springer Publishing Company

Access to resources Recommend Favorite

mTOR inhibitor RAD001 (everolimus) induces apoptotic, not autophagic cell death, in human nasopharyngeal carcinoma cells

By              

International Journal of Molecular Medicine, Vol. 31, Iss. 4, 2013-01 ,pp. : 904-912

Spandidos Publications

Access to resources Recommend Favorite

Rhinitis in Patients Treated with a Combination of an mTOR Inhibitor and an EGFR Inhibitor

By  

Oncology Research and Treatment, Vol. 33, Iss. 7, 2010-06 ,pp. : 401-402

Karger

Access to resources Recommend Favorite